These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27115358)

  • 1. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?
    Ramani S; Estes MK; Atmar RL
    PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 3. Norovirus vaccine development: next steps.
    Atmar RL; Estes MK
    Expert Rev Vaccines; 2012 Sep; 11(9):1023-5. PubMed ID: 23151158
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress on norovirus vaccine research: public health considerations and future directions.
    Mattison CP; Cardemil CV; Hall AJ
    Expert Rev Vaccines; 2018 Sep; 17(9):773-784. PubMed ID: 30092671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of children with norovirus disease in rotavirus vaccine era.
    Wikswo ME; Desai R; Edwards KM; Staat MA; Szilagyi PG; Weinberg GA; Curns AT; Lopman B; Vinjé J; Parashar UD; Payne DC; Hall AJ
    Emerg Infect Dis; 2013 Oct; 19(10):1691-3. PubMed ID: 24047618
    [No Abstract]   [Full Text] [Related]  

  • 6. Norovirus.
    Robilotti E; Deresinski S; Pinsky BA
    Clin Microbiol Rev; 2015 Jan; 28(1):134-64. PubMed ID: 25567225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in human norovirus research and implications for candidate vaccines.
    Cates JE; Vinjé J; Parashar U; Hall AJ
    Expert Rev Vaccines; 2020 Jun; 19(6):539-548. PubMed ID: 32500763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies.
    Atmar RL; Ettayebi K; Ramani S; Neill FH; Lindesmith L; Baric RS; Brinkman A; Braun R; Sherwood J; Estes MK
    J Infect Dis; 2024 May; 229(5):1402-1407. PubMed ID: 37781879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noroviruses: epidemiology, immunity and prospects for prevention.
    Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ
    Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First vaccines targeting 'cruise ship virus' sail into clinical trials.
    Willyard C
    Nat Med; 2013 Sep; 19(9):1076-7. PubMed ID: 24013733
    [No Abstract]   [Full Text] [Related]  

  • 11. A norovirus vaccine on the horizon?
    Vinjé J
    J Infect Dis; 2010 Dec; 202(11):1623-5. PubMed ID: 20979457
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.
    Aliabadi N; Lopman BA; Parashar UD; Hall AJ
    Expert Rev Vaccines; 2015; 14(9):1241-53. PubMed ID: 26224658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic challenges in norovirus vaccine development.
    Hallowell BD; Parashar UD; Hall AJ
    Hum Vaccin Immunother; 2019; 15(6):1279-1283. PubMed ID: 30481104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response.
    Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM
    J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norovirus: Facts and Reflections from Past, Present, and Future.
    Lucero Y; Matson DO; Ashkenazi S; George S; O'Ryan M
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A will to make it happen.
    Sprinks J
    Nurs Stand; 2012 Sep 26-Oct 2; 27(4):20-1. PubMed ID: 23101295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of immunity to norovirus gastroenteritis.
    Simmons K; Gambhir M; Leon J; Lopman B
    Emerg Infect Dis; 2013 Aug; 19(8):1260-7. PubMed ID: 23876612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.